Pilar Manrique, PhD, senior scientist at Microviable Therapeutics will be present at the 10th Microbiome Microbiome Movement Summit taking place in London, in January 28-29th 2026!
Pilar Manrique will be presenting on Thursday 29th at 9:00 am to showcase the latest updates on our microbiota-derived biological medicine MVT-201. From IP, to manufacturing,clinical partnerships and novel medical indications for this unique product. She will go deep on potential applications and preclinical models we have performed to show safety and efficacy, together with the product value proposition and differentiation from fecal capsules used by other companies. Moreover, Pilar will introduce the use of MVT-201 coupled with our drug development platform, PharmaBiota, as a our pipeline development for rationally defined bacterial consortia as novel biological medicines (LBPs).
Do not hesitate to engage with her for any potential discussions!!
About the conference:
Drawing on a decade of industry experience, the 10th Microbiome Movement Summit Europe returned to London as the premiere touchpoint for end-to-end discussions in advancing best-in-class microbiome products beyond traditional gastrointestinal indications. Over the past 10 years, this community has developed robust and impactful preclinical research, now the focus has shifted to translating this into clinical efficacy and driving towards commercial excellence, in spite of industry headwinds.
Senior stakeholders from across the microbiome field, including drug developers, academics, consumer health, pharma, investors, service providers and more, united to overcome shared challenges, spotlight innovations and collaborate in shaping the future of microbiome therapeutics.
If you want to get in touch with us you can do it on the following email: info@microviable.com
